Cooper Companies (NASDAQ:COO) Releases FY 2025 Earnings Guidance

Cooper Companies (NASDAQ:COO - Get Free Report) issued an update on its FY 2025 earnings guidance on Thursday morning. The company provided EPS guidance of 4.050-4.110 for the period, compared to the consensus EPS estimate of 3.990. The company issued revenue guidance of $4.1 billion-$4.1 billion, compared to the consensus revenue estimate of $4.1 billion.

Cooper Companies Trading Down 0.1%

NASDAQ:COO traded down $0.09 during midday trading on Tuesday, reaching $66.91. 4,101,096 shares of the stock traded hands, compared to its average volume of 1,556,509. The company has a fifty day moving average of $79.48 and a 200 day moving average of $88.06. Cooper Companies has a 12 month low of $65.06 and a 12 month high of $112.38. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91. The stock has a market capitalization of $13.38 billion, a P/E ratio of 34.31, a PEG ratio of 2.25 and a beta of 1.08.

Cooper Companies (NASDAQ:COO - Get Free Report) last issued its quarterly earnings data on Thursday, May 29th. The medical device company reported $0.96 EPS for the quarter, topping the consensus estimate of $0.93 by $0.03. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The business had revenue of $1 billion during the quarter, compared to analyst estimates of $995.12 million. During the same period in the prior year, the business earned $0.85 EPS. The company's revenue for the quarter was up 6.3% on a year-over-year basis. On average, research analysts predict that Cooper Companies will post 3.98 EPS for the current year.

Wall Street Analysts Forecast Growth

Several research analysts recently issued reports on the stock. JPMorgan Chase & Co. reiterated a "neutral" rating and issued a $76.00 price target (down from $110.00) on shares of Cooper Companies in a research note on Friday. Wells Fargo & Company decreased their target price on shares of Cooper Companies from $118.00 to $93.00 and set an "overweight" rating on the stock in a research note on Friday. Needham & Company LLC restated a "hold" rating on shares of Cooper Companies in a research report on Thursday, May 22nd. Stifel Nicolaus dropped their price objective on shares of Cooper Companies from $115.00 to $105.00 and set a "buy" rating for the company in a research note on Friday, March 7th. Finally, Piper Sandler restated an "overweight" rating and issued a $105.00 price objective (down from $115.00) on shares of Cooper Companies in a report on Friday. Four investment analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to MarketBeat, Cooper Companies presently has an average rating of "Moderate Buy" and a consensus price target of $100.38.

Hedge Funds Weigh In On Cooper Companies

An institutional investor recently raised its position in Cooper Companies stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 48.9% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 22,407 shares of the medical device company's stock after acquiring an additional 7,363 shares during the quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.'s holdings in Cooper Companies were worth $1,890,000 as of its most recent SEC filing. Institutional investors and hedge funds own 24.39% of the company's stock.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.